等待开盘 12-19 09:30:00 美东时间
+0.870
+2.51%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
12-18 10:54
JP Morgan analyst Benjamin Rossi reinstates PACS Group (NYSE:PACS) with a Overweight and announces $44 price target.
12-17 21:48
社交电商平台WeShop上市一周涨超275%;精密科学周涨超50%,获雅培230亿美元收购;SEMrush周涨近67%,获Adobe收购>>
11-22 10:30
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
11-21 15:50
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) stock increased by 18.6% to $2.1...
11-21 05:06
RBC Capital analyst Ben Hendrix maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $32 to $33.
11-20 23:11
InMed shares jumped 22% in after-hours trading after the company reported encouraging large-animal study results for its Alzheimer's drug candidate INM-901.
11-20 15:28
Magnera shares jumped over 28% in after-hours trading Wednesday after the company reported strong fourth-quarter results and record cash generation for fiscal 2025.
11-20 13:30
PACS Group shares surged in after-hours trading following strong third -quarter results and the completion of financial restatements.
11-20 12:35
PACS Group将于2025年11月19日盘后发布2025财年季报,预期每股收益0.38美元,营收10.1亿美元,该财报数据将为评估公司财务状况和业务发展提供重要参考。
11-20 05:42